BCR-ABL–specific T-cell therapy in Ph(+) ALL patients on tyrosine-kinase inhibitors

Although the emergence of bone marrow (BM)–resident (p190)BCR-ABL–specific T lymphocytes has been correlated with hematologic and cytogenetic remissions in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph(+) ALL) undergoing maintenance tyrosine-kinase inhibitor treatme...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood
Hlavní autoři: Comoli, Patrizia, Basso, Sabrina, Riva, Giovanni, Barozzi, Patrizia, Guido, Ilaria, Gurrado, Antonella, Quartuccio, Giuseppe, Rubert, Laura, Lagreca, Ivana, Vallerini, Daniela, Forghieri, Fabio, Morselli, Monica, Bresciani, Paola, Cuoghi, Angela, Paolini, Ambra, Colaci, Elisabetta, Marasca, Roberto, Cuneo, Antonio, Iughetti, Lorenzo, Trenti, Tommaso, Narni, Franco, Foà, Robin, Zecca, Marco, Luppi, Mario, Potenza, Leonardo
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2017
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290986/
https://ncbi.nlm.nih.gov/pubmed/27927646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-07-731091
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky